Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Telephone-based physical activity counseling for major depression in people with multiple sclerosis.
Structural brain lesions in inflammatory bowel disease.
Cover Images.
Cognitive and brain reserve for mind-body therapeutic approaches in multiple sclerosis: A review.
[Current Status of Genetic Diagnosis of Charcot-Marie-Tooth Disease: Variety of the Disease-causing Genes].
Disease modification in multiple sclerosis: an update.
Increased Plasma Interleukin-32 Expression in Patients with Neuromyelitis Optica.
Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability.
Immune- and miRNA-response to recombinant interferon beta-1a: a biomarker evaluation study to guide the development of novel type I interferon- based therapies.
Functionally Relevant White Matter Degradation in Multiple Sclerosis: A Tract-based Spatial Meta-Analysis.
Induction of cognitive fatigue in MS patients through cognitive and physical load.
Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis.
The role of cerebellar abnormalities in neuromyelitis optica - a comparison with multiple sclerosis and healthy controls.
TREM2 regulates microglial cell activation in response to demyelination in vivo.
Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis.
Acute retinal necrosis in multiple sclerosis: A neuroimmunologic challenge!
Removal of access to alemtuzumab for patients with aggressive multiple sclerosis.
Isolation of bacterial plasmid-related replication-associated circular DNA from a serum sample of a multiple sclerosis patient.
Blind analysis: Hide results to seek the truth.
Defining Quality of Life Levels to Enhance Clinical Interpretation in Multiple Sclerosis: Application of a Novel Clustering Method.
Childhood inflammatory brain diseases: pathogenesis, diagnosis and therapy.
A nexus between lipids and multiple sclerosis?
Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches.
Newly produced T and B lymphocytes and T-cell receptor repertoire diversity are reduced in peripheral blood of fingolimod-treated multiple sclerosis patients.
Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors.

Pages